Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus

Acta Derm Venereol. 2000 Mar-Apr;80(2):134-5.

Abstract

Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.

Publication types

  • Case Reports

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis
  • AIDS-Related Opportunistic Infections / drug therapy*
  • Adjuvants, Immunologic / administration & dosage*
  • Administration, Topical
  • Adult
  • Aminoquinolines / administration & dosage*
  • Facial Dermatoses / diagnosis
  • Facial Dermatoses / drug therapy
  • Follow-Up Studies
  • Humans
  • Imiquimod
  • Male
  • Ointments
  • Treatment Outcome
  • Warts / diagnosis
  • Warts / drug therapy*

Substances

  • Adjuvants, Immunologic
  • Aminoquinolines
  • Ointments
  • Imiquimod